Abstract
Background
Limited information exists regarding the association between subjective well‐being (SWB) and systolic blood pressure (SBP) among hypertensive patients with coronary artery disease (CAD).
Hypothesis
We tested the hypothesis that there is an association between SBP and SWB.
Methods
We studied 22,576 hypertensive CAD patients ≥ 50 years old in the INternational VErapamil SR‐Trandolapril Study (INVEST), a randomized, blinded‐endpoint trial of antihypertensive therapy in stable CAD patients. At each study visit, patients rated their SWB in the previous 4 weeks as “excellent,” “good,” “fair,” or “poor” prior to SBP recordings. The outcome measure was SWB of “fair” or “poor.” A longitudinal analysis using generalized estimating equations was performed to assess the association between SBP and odds of reporting fair/poor SWB, controlling for baseline SWB of fair/poor and angina reported during the study.
Results
Patients with higher SBP had higher odds of reporting fair/poor SWB. Specifically, compared with patients with SBP of ≤ 120, patients with SBP 140–150 > 150 − ≤ 160 and > 160 had about 90% and 2.5 times greater odds of feeling fair/poor, respectively (adjusted odds ratio [OR]: 1.5990, 95% confidence interval [CI]: 1.81–2.00 and adjusted OR: 2.53, 95% CI: 2.41–2.66). Those who reported angina in the 4 wks prior to a protocol visit had 2.2 times greater odds of reporting fair/poor SWB (adjusted OR: 2.2, 95% CI: 2.13–2.27). Female gender, black race, history of smoking, diabetes, myocardial infarction, stroke, and cancer also increased the odds of reporting fair/poor SWB.
Conclusions
Among hypertensive CAD patients, higher on‐treatment SBP is associated with greater odds of fair/poor SWB during follow‐up. Copyright © 2009 Wiley Periodicals, Inc.
Full Text
The Full Text of this article is available as a PDF (132.5 KB).
REFERENCES
- 1. Cote I, Gregoire JP, Moisan J: Health‐related quality‐of‐life measurement in hypertension. A review of randomised controlled drug trials. Pharmacoeconomics 2000; 18:435–450. [DOI] [PubMed] [Google Scholar]
- 2. Li W, Liu L, Puente JG, Li Y, Jiang X, et al: Hypertension and health‐related quality of life: An epidemiological study in patients attending hospital clinics in china. J Hypertens 2005; 23:1667–1676. [DOI] [PubMed] [Google Scholar]
- 3. Bardage C, Isacson DG: Hypertension and health‐related quality of life. An epidemiological study in Sweden. J Clin Epidemiol 2001; 54:172–181. [DOI] [PubMed] [Google Scholar]
- 4. Pepine CJ, Handberg EM, Cooper‐DeHoff RM, Marks RG, Kowey P, et al: A calcium antagonist vs a non‐calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The international verapamil‐trandolapril study (invest): A randomized controlled trial. JAMA 2003; 290:2805–2816. [DOI] [PubMed] [Google Scholar]
- 5. Pepine CJ, Handberg‐Thurmond E, Marks RG, Conlon M, Cooper‐DeHoff R, et al: Rationale and design of the international verapamil sr/trandolapril study (invest): An internet‐based randomized trial in coronary artery disease patients with hypertension. J Am Coll Cardiol 1998; 32:1228–1237. [DOI] [PubMed] [Google Scholar]
- 6. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413–2446. [DOI] [PubMed] [Google Scholar]
- 7. Ried LD, Tueth MJ, Handberg E, Nyanteh H: Validating a self‐report measure of global subjective well‐being to predict adverse clinical outcomes. Qual Life Res 2006; 15:675–686. [DOI] [PubMed] [Google Scholar]
- 8. Wilson IB, Cleary PD: Linking clinical variables with health‐related quality of life. A conceptual model of patient outcomes. JAMA 1995; 273:59–65. [PubMed] [Google Scholar]
- 9. Hlatky MA: Coronary revascularization and quality of life. Am Heart J 2004; 148:5–6. [DOI] [PubMed] [Google Scholar]
- 10. Melsop KA, Boothroyd DB, Hlatky MA: Quality of life and time trade‐off utility measures in patients with coronary artery disease. Am Heart J 2003; 145:36–41. [DOI] [PubMed] [Google Scholar]
- 11. Pocock SJ, Henderson RA, Clayton T, Lyman GH, Chamberlain DA: Quality of life after coronary angioplasty or continued medical treatment for angina: Three‐year follow‐up in the rita‐2 trial. Randomized intervention treatment of angina. J Am Coll Cardiol 2000; 35:907–914. [DOI] [PubMed] [Google Scholar]
- 12. Norris CM, Ghali WA, Galbraith PD, Graham MM, Jensen LA, et al: Women with coronary artery disease report worse health‐related quality of life outcomes compared to men. Health Qual Life Outcomes 2004; 2:21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Banegas JR, Lopez‐Garcia E, Graciani A, Guallar‐Castillon P, Gutierrez‐Fisac JL, et al: Relationship between obesity, hypertension and diabetes, and health‐related quality of life among the elderly. Eur J Cardiovasc Prev Rehabil 2007; 14:456–462. [DOI] [PubMed] [Google Scholar]
- 14. Kouba E, Hubbard JS, Moore D, Wallen EM, Pruthi RS: A prospective evaluation of the short‐term impact and recovery of health‐related quality of life in men undergoing radical prostatectomy. BJU Int 2007; 99:72–76. [DOI] [PubMed] [Google Scholar]
- 15. Kovac SH, Mikuls TR, Mudano A, Saag KG: Health‐related quality of life among self‐reported arthritis sufferers: Effects of race/ ethnicity and residence. Qual Life Res 2006; 15:451–460. [DOI] [PubMed] [Google Scholar]
- 16. Fallon EM, Tanofsky‐Kraff M, Norman AC, McDuffie JR, Taylor ED, et al: Health‐related quality of life in overweight and nonoverweight black and white adolescents. J Pediatr 2005; 147:443–450. [DOI] [PMC free article] [PubMed] [Google Scholar]